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esponsibility of InstAbstract Vascular endothelial growth factor (VEGF) is associated with endothelial cell proliferation,
migration and angiogenesis. Estrogen-related receptor γ (ERRγ) plays important regulatory roles in fatty
acid oxidation, mitochondrial biogenesis and gluconeogenesis. Recently, ERRγ has been shown to be
involved in angiogenesis; however, the mechanism of ERRγ-mediated angiogenesis is poorly understood.
Here the results show that ERRγ activates VEGF gene transcription via two putative estrogen-related
receptor binding elements (ERREs) mapped to the promoter region. Chromatin immunoprecipitation
assays conﬁrmed that ERRγ binds to the identiﬁed ERREs. Adenovirus-mediated overexpression of ERRγ
increased the expression of VEGF gene and induced an increase in VEGF secretion in C2C12 myotubes.
In contrast, the secretion of VEGF was signiﬁcantly decreased in the presence of the ERRγ inverse agonist
GSK5182. Furthermore, treatment of human umbilical vein endothelial cells (HUVECs) with the
conditioned medium from ERRγ-overexpressing C2C12 myotubes signiﬁcantly increased proliferation,
migration and tube formation. These data indicate that VEGF functions as a downstream target gene of
ERRγ and mediates the effects of ERRγ on endothelial cells proliferation, migration and angiogenesis.
This physiological function of ERRγ might provide a novel target for treatment of ischemic diseases.
& 2013 Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical
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VEGF is a potent endothelial cell mitogen known to play key roles in
vasculogenesis, angiogenesis and early postnatal life1. Genomic
deletion of the VEGF gene in mice results in embryonic lethality
due to a poorly organized cardiovascular network2. Oxygen tension
plays an important role in regulating the expression of VEGF and
hypoxia-inducible factor-1 alpha is the key mediator of the hypoxic
responses3. Estrogen receptors have a direct transcriptional effect on
VEGF gene expression4,5. Secretion of VEGF and other angiogenic
factors results in neovascularization, thus VEGF provides an important
target treatment for ischemic diseases in human.
Peroxisome proliferator-activated receptor γ coactivator-1α
(PGC-1α) is a multifunctional transcriptional coactivator that
regulates oxidative and mitochondrial metabolism in many tissues
including muscle. Some genes induced by hypoxia and ischemia
are regulated by PGC-1α, such as the glucose transporter6. PGC-
1α regulates gene expression through coactivation of many
transcription factors including the estrogen receptor and the
estrogen-related receptor7. PGC-1α expression levels are elevated
in various tissues by a number of external stimuli: hypobaric
hypoxia elevates PGC-1α expression in mouse cerebral subcor-
tex8; cold temperatures elevate PGC-1α in brown adipose tissue;
fasting leads to elevated expression in the liver; and exercise and
decreased ATP levels increase expression in skeletal muscle9.
Estrogen-related receptors (ERRs) belong to the family of
orphan nuclear hormone receptors including ERRα, ERRβ, and
ERRγ10. ERRγ is most highly expressed in the heart, brain, kidney
and skeletal muscle11. It seems that ERRγ is an orphan receptor
that does not require agonist-dependent activation12. Deletion of
the ERRγ gene in the mouse is perinatal lethal, and analysis of the
phenotype of this mouse model indicates ERRγ is essential for the
transition from glycolysis to fatty acid oxidation in cardiac muscle
during early postnatal life13. Several genes are reported to be
regulated by ERRγ, including SHP, PDK4, DAX-1 and MAO.
Recent studies in ERRγ-null mice demonstrated that ERRγ
regulates potassium homeostasis in the heart, kidney and sto-
mach14. These studies focused on its role in energy metabolism.
However, the ability of ERRγ to regulate endothelial cell
proliferation, migration and angiogenesis remains unknown.
In this study, it is showed that levels of ERRγ and VEGF are
elevated in the mouse soleus muscle in response to exercise.
Adenovirus-mediated overexpression of ERRγ (Ad-ERRγ) stimu-
lates VEGF expression and release in skeletal muscle cells.
Moreover, we demonstrate that ERRγ regulates the expression of
VEGF by binding to the two putative estrogen-related receptor
binding elements (ERREs) in the VEGF promoter. Furthermore,
conditioned medium from Ad-ERRγ-transfected C2C12 myotubes
enhances primary human umbilical vein endothelial cell prolifera-
tion, migration and tube formation.2. Materials and methods
2.1. Cell culture, adenovirus infection and reagents
HepG2 and C2C12 cells from ATCC were cultured in DMEM
supplemented with 10% fetal bovine serum (FBS). Myotube
differentiation was induced as previously reported15. After infec-
tion with the indicated adenoviruses, myotubes were washed with
PBS for ﬁve times and cultured in fresh RPMI1640 supplemented
with 1% FBS. After 48 h, the conditioned medium from four-daydifferentiated control or ERRγ over-expressing C2C12 myotubes
was collected and stored at 70 1C before use. Primary mouse
hepatocytes from the livers of 8-10-week old male C57BL/6 J
mice were isolated and maintained as previously described15.
Human monocytic cell line THP-1 cells were maintained in RPMI
1640 supplemented with 10% FBS. THP-1 cells were differen-
tiated into adherent macrophages by treatment with 3 108–
30 108 M phorbol 12-myristate 13-acetate (PMA) for 72 h.
Cells were infected with the indicated adenoviruses at a multi-
plicity of infection sufﬁcient to infect 495% of cells as
determined by GFP ﬂuorescence. The VEGF enzyme-linked
immunoassay kit was from SciMall, Shanghai, China. GSK5182
was synthesized as previously described16. HUVECs were isolated
from fresh umbilical cord as previously described17. Cells were
cultured in RPMI1640 medium, containing 20% fetal
bovine serum.2.2. Exercise training
8 to 10-week-old male C57BL/6J mice were trained for a period of
8 days by running on a treadmill (12 m/min) for 2 h per day in the
morning. Tissues were isolated immediately after the last bout of
exercise training and total RNA was extracted using Trizol reagent
for real-time PCR analysis.2.3. Plasmid constructs
The mouse VEGF promoter (1508 to þ125 bp, referred to as
-1508Luc) was ampliﬁed by PCR using mouse genomic DNA and
cloned at HindIII and MluI sites of pGL3-basic reporter vector
(Promega). To amplify different promoter regions, corresponding
forward primers 5′-CTCAGAAGTCCAGCAGATC-3′ (-1508Luc),
5′-TTCCACAGGTCGTCTCACT-3′ (-916Luc), 5′-AAGTCTGC
CGCACTCAAG-3′ (-608Luc), 5′-CCTCATACGTCCCTGCC-3′
(-355Luc) were used with the same reverse primer (5′-CTGGTGA-
GTCCGCTGAATAG-3′). The site-direct mutagenesis was performed
using the QuikChange kit (Stratagene, La Jolla, CA) according to the
manufacturer's protocol. The wild-type oligonucleotide of ERRE1 and
ERRE2 were 5′-ATGCTTCCGAGGTCAAACACGCAA-3′ and
5′-GAAAGCCAGGGGTCACTCTAGTTG-3′, whereas the mutant
oligonucleotide of ERRE1 and ERRE2 were 5′-ATGCTTCC-
GATTGTGAACACGCAA-3′ and 5′-GAAAGCCAGTTTGTGCTC-
TAGTTG-3′. Clones were veriﬁed by sequencing. Adenovirus vectors
expressing GFP, PGC-1α or ERRγ were prepared in our laboratory as
previously described.2.4. Transient transfection and luciferase assay
HepG2 cells were cultured in 24-well plates and transient
transfection was performed as recommended by the manufacturer
(Vigorous, Beijing, China). The DNA constructs harboring the
5′-deletion series of VEGF promoter or the mutant construct fused
to luciferase reporter were cotransfected into HepG2 cells together
with pcDNA3.1 (control) or ERRγ in the presence or absence of
PGC-1α expression plasmids. 48 h after transfection, luciferase
reporter assays were performed using the Dual Luciferase Reporter
Assay System (Promega).
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C2C12 myotubes were cultured and infected with adenoviruses
expressing ERRγ-Flag, or GFP. After 48 h, cells were harvested
in PBS and cross-linked by 1% formaldehyde, lysed and
subjected to chromatin shearing by sonication. Samples were
immunoprecipitated with anti-Flag (Sigma), or normal mouse
control IgG (Sigma), followed by incubation with protein G-
Sepharose. After chromatin immunoprecipitation, DNA was
puriﬁed by phenol/chloroform extraction and used for PCR
ampliﬁcation. The primers were designed to amplify the region
770 to 591 bp or 454 to 291 bp of the mouse VEGF
promoter containing two putative ERRγ binding sites, ERRE1(–
AGGTCA–): 5′-TCCTGATGACTGCAGATCAGAC-3′ (for-
ward) and 5′-CTTGAGTGCGGCAGACTTTG-3′ (reverse);
ERRE2 (–GGGTCA–): 5′-ACGCGTGTGTCAATGTGAGTGC-
3′ (forward) and 5′-CCTTTCCCAGGAATATAGGAGA-3′
(reverse).
2.6. Real-time PCR
Total RNA was extracted by Trizol reagent and submitted for cDNA
synthesis using random hexamers and a reverse transcription kit
(Invitrogen, Carlsbad, CA). For gene expression analysis, real-time
PCR was performed using a BioRad IQ5 instrument and SYBR super
mix (Promega). GAPDH was used as an internal control.
2.7. Cellular proliferation/migration assay
HUVECs (2 104 cells/well) were plated in 48-well plates. After 24 h,
cells were washed ﬁve times with PBS and incubated with indicated
conditioned medium for 48 h. Proliferation was measured using the
thiazolyl blue tetrazolium bromide (MTT) colorimetric assay according
to the manufacturer's recommendation (Sigma).
The cell migration assay was performed in a 24-well Boyden
chamber. HUVECs were resuspended in RPMI1640 supplemented
with bovine serum albumin (0.5%) and added to the upper
chamber of the well, and the indicated conditioned medium was
used as chemoattractant in the lower chamber. The cells were
allowed to migrate for 12 h. Non-migratory cells were removed
from the upper surface by scraping with a cotton swab. Migrated
cells were ﬁxed and stained with Hoechst 33342 dye. The number
of cells was counted using lmaris software. Experiments were
performed in triplicate.
2.8. Tube formation by HUVECs
A tube-formation assay was performed with a transwell system.
Brieﬂy, cells (5 104 cells/200 μL) were seeded into the upper
chamber; 24 h after seeding, the medium were replaced with fresh
RPMI1640 supplemented with 10% bovine serum albumin and 50%
conditioned medium. The cells were incubated at 37 1C for 96 h. Cells
were stained and different microscopic ﬁelds (100 ) were
photographed.
2.9. Statistical analysis
Data represent as means7S.D. of at least three independent
experiments. Differences between groups were compared by
student's t test and Po0.05 was considered statistically
signiﬁcant.3. Results
3.1. Muscle VEGF and ERRγ expression is upregulated
by exercise
To explore the physiological role of ERRγ in exercise-induced
angiogenesis, we ﬁrst studied the expression level of ERRγ in the
mouse soleus muscle. Our data indicated that the ERRγ mRNA
level was increased approximately 2-fold in the soleus muscle in
response to exercise (Fig. 1A). Interestingly, VEGF showed a
similar expression pattern in the soleus muscle in response to
exercise (Fig. 1B).
As we observed a similar physiological upregulation of ERRγ
and VEGF in response to exercise, we wondered whether ERRγ
could affect the expression of the VEGF gene. To answer this
question, adenovirus-mediated expression of ERRγ (Ad-ERRγ)
was generated and the effect of ERRγ overexpression on VEGF
mRNA expression was examined. As shown in Fig. 1C, exposure
of C2C12 myotubes to Ad-ERRγ resulted in 2.8-fold increase in
VEGF mRNA levels compared with Ad-GFP treatment. In
addition, an upregulation of VEGF mRNA upon overexpression
of ERRγ in primary mouse hepatocytes was detected (Fig. 1D).
Similar results were observed in HepG2 and THP-1 cells (Fig. 1E
and F). Indeed, our microarray data also suggest VEGF as a
potential target gene of PGC-1α in hepatocytes. Therefore, we
investigated whether PGC-1α played a direct role in the regulation
of VEGF gene expression. Adenovirus-mediated overexpression
of PGC-1α resulted in a 1.8-fold up-regulation of VEGF mRNA in
primary mouse hepatocytes (data not shown). These data indicated
that ERRγ and PGC-1α functioned as upstream activators of
VEGF gene expression in myotubes and hepatocytes.3.2. Transactivation of VEGF promoter by ERRγ
To test whether ERRγ-mediated stimulation of VEGF gene
expression occurred at the transcriptional level, a construct
containing the mouse VEGF promoter was inserted into the
reporter vector (pGL3-Basic) and transfected into HepG2 cells.
Two putative ERR response elements (ERREs), located from
676 to 665 bp and 380 to 368 bp were found in VEGF
promoter. First, a 1.5-kb-length (1508 to þ125 bp) fragment of
the VEGF gene promoter region fused to the luciferase reporter
vector (Luc-1508) was constructed. Cotransfection of the ERRγ
expression vector with Luc-1508 resulted in a 3.8-fold activation
of the reporter gene (Fig. 2A). In contrast, the transfection of the
ERRα expression plasmid into HepG2 cells did not cause any
activation of VEGF promoter (data not shown). Second, to map
the cis-acting element conferring the ERRγ-induced stimulation of
luciferase, a series of 5′ deletions of the VEGF promoter fused
to the reporter vector were generated and the plasmids were
transfected into HepG2 cells. As shown in Fig. 2A, ERRγ-
mediated reporter gene activation was not signiﬁcantly decreased
upon the deletion of the 1508 to 608 bp region (still contain-
ing one putative ERRE) upstream of VEGF promoter transcription
start site. However, when the reporter gene was further deleted to
355/þ125 bp (missing two putative ERREs), the activation by
ERRγ was almost completely lost (Fig. 2A).
Next, we searched for the sequence motif in the VEGF
promoter response to ERRγ and PGC-1α. HNF4 and ERRγ were
reported to be coactivated by PGC-1α and several putative binding
Figure 1 The expression levels of ERRγ and VEGF in soleus muscle are increased in response to exercise, and ERRγ regulates the expression of
VEGF. Real-time PCR analysis of ERRγ (A) and VEGF (B) expression in mouse soleus muscle in rested (n¼6) and exercised (n¼6) mice
(*Po0.05 vs. rest condition). Differentiated C2C12 cells (C), primary mouse hepatocytes (D), HepG2 (E), and THP-1(differentiated into adherent
macrophages) (F) cells were infected with adenoviruses expressing GFP (Ad-GFP) or ERRγ (Ad-ERRγ), and mRNA levels of VEGF were
quantiﬁed by real-time PCR. *Po0.05 vs. GFP control.
Figure 2 Activation of the VEGF promoter by ERRγ in HepG2 cells. The relative luciferase activity in HepG2 cells transfected with reporter
plasmid containing the VEGF promoter deletion (A) or mutation (B) constructs is shown; wt, wild-type; mut, mutant. (C) C2C12 cells were treated
as described in materials and methods and ChIP assays were performed. The resultant DNA was analyzed by PCR with primers to amplify the
promoter region ﬂanking the VEGF ERREs. *Po0.05 vs. control.
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of VEGF. To examine whether these transcription factors can
activate the VEGF promoter together with PGC-1α, plasmids
expressing these nuclear receptors with or without PGC-1α were
co-transfected into HepG2 cells along with the reporter vector
containing VEGF promoter fragments. HNF4 co-transfected with
PGC-1α had no coactivation effect on luciferase activity as
compared with cells transfected with PGC-1α alone (data not
shown). As shown in Fig. 2A, cotransfection of PGC-1α and
ERRγ led to a robust activation of the promoter. However, this
activation was completely lost when the two ERREs in the VEGF
promoter were deleted (Fig. 2A).
To further conﬁrm the involvement of the two ERREs in the
response to ERRγ/PGC-1α in the VEGF promoter, the potential
ERRγ binding sites were mutated in the Luc-1508 construct. When
either putative ERRE in the VEGF promoter was mutated, the
activation of the mutant construct (MUT1 or MUT2) by ERRγ or
ERRγ/PGC-1α was modestly suppressed. However when both of
the ERREs were mutated (MUT1þ2) activation was completely
lost (Fig. 2B). These results indicate that both ERREs are
functional ERRγ cis-elements and that mutation of either ERRE
alone does not block completely the ERRγ-mediated activation of
VEGF gene expression.Figure 3 Regulation of VEGF secretion by ERRγ in C2C12 cells. C2C12
(Ad-GFP) or FLAG-tagged ERRγ (Ad-ERRγ); protein (A) and mRNA (B)
PCR. (C) The VEGF concentration in the conditioned medium from differe
measured by ELISA. (D) Cells were infected with Ad-GFP or Ad-ER
ﬂuorescence. (E) C2C12 myotubes were treated with dimethyl sulfoxide (D
conditioned medium was measured by ELISA. *Po0.05 vs. GFP control.3.3. ERRγ interacts with the ERREs in the VEGF promoter
To determine whether ERRγ bound to the putative ERREs in the
VEGF promoter, chromatin immunoprecipitation (ChIP) assays
were performed with chromatin isolated from C2C12 myotubes
infected with adenovirus-mediated expression of ERRγ-Flag
(Ad-ERRγ-Flag) or adenovirus-mediated expression of green
ﬂuorescent protein (Ad-GFP). Cross-linked chromatin fragments
were precipitated with the indicated antibodies against Flag or the
control IgG and used for ampliﬁcation by PCR. The two ERREs in
the VEGF promoter could be ampliﬁed from the precipitates
obtained using the Flag antibody but not the control IgG sample
(Fig. 2C). In addition, a weak ampliﬁcation of the same ERRE
sequences in the VEGF promoter could be obtained via immuno-
precipitation with anti-PGC-1α antibody (data not shown). These
results demonstrate that ERRγ binds to the VEGF promoter in vivo.3.4. Overexpression of ERRγ in cultured myotubes results in an
increase of VEGF secretion into the medium
Thereafter, we studied whether ERRγ inﬂuenced VEGF secretion
from C2C12 myotubes. C2C12 myoblasts were differentiated tomyotubes were infected with adenovirus-mediated expression of GFP
expression of ERRγ was analyzed by Western Blotting and real-time
ntiated control and ERRγ-overexpressing C2C12 myotubes (n¼3) was
Rγ and the infection efﬁciency was determined by assaying GFP
MSO, control) or 1 μM GSK5182 for 72 h. The VEGF protein in the
J. Liang et al.378myotubes and exposed to Ad-ERRγ or Ad-GFP control. We observed
an upregulation of ERRγ in the C2C12 myotubes infected with Ad-
ERRγ compared with Ad-GFP (Fig. 3A and B). We examined the
VEGF protein levels in the conditioned medium. ELISA results
showed that overexpression of ERRγ in C2C12 myotubes led to a
2-fold induction of secretion of VEGF protein into the cell culture
medium as compared with the GFP control (Fig. 3C). The infection
efﬁciency was determined by assaying GFP ﬂuorescence (Fig. 3D).
In contrast, treatment with the ERRγ inverse agonist GSK5182
decreased the VEGF secretion from the C2C12 myotubes into the
medium (Fig. 3E).3.5. Regulation of HUVEC proliferation, migration and tube
formation by conditioned medium from Ad-ERRγ-treated myotubes
To test whether the conditioned medium from ERRγ-stimulated
myotubes can promote endothelial cell proliferation, myotubes were
infected with indicated adenovirus for 48 h and conditioned medium
was collected as described in materials and methods. The presence of
conditioned medium from ERRγ-treated myotubes signiﬁcantly
increased the proliferation of HUVECs compared with conditioned
medium from GFP-treated myotubes (Fig. 4A).Figure 4 Conditioned medium from ERRγ-overexpressing C2C12 myotu
HUVECs were treated as described in materials and methods, and relative
were seeded in the upper chamber of a 24-well transwell chamber and
chamber. After 12 h, the nuclei of migrated cells were stained with Hoech
were cultured as described in the materials and methods and tube formatio
formation. *Po0.05 vs. control.We investigated whether the enhanced release of VEGF
induced by treatment with ERRγ in C2C12 myotubes resulted in
a true increment in the angiogenic potential of the endothelial cells
by testing the ability of the conditioned medium to stimulate the
migration of HUVECs. A transwell migration assay showed that
conditioned medium from myotubes treated with ERRγ caused
greater endothelial cells migration compared with the GFP-treated
control (Fig. 4B).
The key aspect of angiogenesis is the formation of
capillaries from endothelial cells. To determine if the conditioned
medium from Ad-ERRγ-treated C2C12 myotubes can enhance
HUVEC tube formation, HUVECs were cultured in a
24-well transwell chamber in RPMI1640, supplemented with
20% FBS. 24 h later, the medium was replaced with fresh
RPMI1640 supplemented with 2% FBS and 50% conditioned
medium. Indeed, treatment of HUVECs with conditioned medium
from ERRγ-treated C2C12 myotubes increased tube formation at
72 h (Fig. 4C).
These results indicate that VEGF protein expression and
secretion is markedly induced by ERRγ expression, and the
proliferation, migration and tube formation of HUVECs might
be mediated by the VEGF in the conditioned medium released by
myotubes infected with Ad-ERRγ.bes increased HUVEC proliferation, migration and tube formation. (A)
cellular proliferation was measured by the MTT assay. (B) HUVECs
the conditioned medium was used as a chemoattractant in the lower
st 33342 and the number of migrated cells was counted. (C) HUVECs
n by the cells was determined. The arrow indicates tube-like structure
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ERRγ is constitutively active and it assumes an activated con-
formation in the absence of additional ligand8. The present study
demonstrates that ERRγ alone is sufﬁcient to stimulate VEGF
expression at the transcriptional level. PGC-1α can also induce
VEGF expression, and this effect might be partly mediated by
ERRγ binding to the ERRE present in the promoter of VEGF. For
more than ﬁfteen years, intense investigations have indicated that
VEGF plays important roles in the regulation of pathological
angiogenesis and tumor growth18. However, VEGF also represents
a key rate-limiting step in physiological angiogenesis19. VEGF
gene expression is regulated by oxygen tension, oncogenes and
several growth factors including TGF-α, KGF and PDGF1. In
addition, exercise induces expression of VEGF in human skeletal
muscle, which is consistent with our ﬁndings20. The transcriptional
coactivator PGC-1α is expressed in tissues with high energy
metabolism, such as BAT, heart, and skeletal muscle, and exercise
stimulates PGC-1α expression in skeletal21,22. ERRγ expression is
also induced by exercise23. Current investigations on PGC-1α and
ERRγ mainly focus on their ability to regulate energy metabolism.
However, the roles they play in endothelial cell proliferation,
migration and angiogenesis are largely unknown. Given the fact
that ERRγ and VEGF are induced in the soleus muscle by
exercise, we asked whether ERRγ can regulate VEGF expression
and promote VEGF-mediated actions. To answer this question, we
ﬁrst cloned the VEGF promoter by PCR ampliﬁcation of mouse
genomic DNA, inserted the cloned DNA into the reporter vector
pGL3-Basic. Overexpression of ERRγ or ERRγ/PGC-1α led to a
3.8-fold and nearly 6-fold induction of VEGF promoter activity,
respectively. PGC-1α is known to coactivate ERRα, ERRγ and
other transcriptional factors. Co-transfection of ERRα with PGC-
1α also resulted in a 6-fold induction of VEGF promoter activity.
However, the addition of ERRα alone had no effect on luciferase
activity differentiating its actions from ERRγ. These data indicated
that ERRγ, not ERRα, might be an essential mediator of PGC-1α-
dependent and independent angiogenesis.
Indeed, Rangwala et al.23 reported that ERRγ can induce VEGF
promoter activity, consistent with our data. However, they did not
map the ERRγ binding sites in the VEGF promoter. ERRα and
ERRγ have been reported to bind the conserved sequence
AGGTCA24; motif analysis of the VEGF promoter indicated two
potential ERR binding sites located between 1508 and 355 bp.
Our ChIP analysis demonstrated that ERRγ bound to the two
ERREs in the VEGF promoter. Furthermore, treatment with the
ERRγ inverse agonist GSK5182 decreased VEGF expression and
secretion in C2C12 myotubes. Arany et al.19 reported that silencing
of ERRα expression abolished PGC-1α-induced VEGF expression,
and they demonstrated that ERRα alone was sufﬁcient to induce
VEGF expression by 3-fold in primary skeletal muscle cells.
However, our results indicated that transfected HepG2 cells with
an ERRα expression vector had no effect on VEGF promoter
activity (data not shown). These paradoxical results may be caused
by different experimental conditions.
Endothelial cell proliferation, migration and tube formation are
especially important in angiogenesis. Upregulation of VEGF and
improved angiogenesis is the major physiological response to
exercise and hypoxia in the microenvironment4,25. In this study we
demonstrated that ERRγ and VEGF expression were increased in
response to exercise. Based on these facts, we speculate that ERRγ
may promote VEGF secretion and contribute to VEGF-induced
endothelial cell proliferation, migration and angiogenesis. Wefound that overexpression of ERRγ resulted in increased VEGF
secretion from C2C12 myotubes. This effect of ERRγ is PGC-1α-
independent, but enhanced in presence of PGC-1α.
In conclusion, ERRγ can induce VEGF expression and secre-
tion through binding to the two ERREs in the VEGF promoter,
and this effect can be enhanced by PGC-1α co-expression. Small
molecules that induce the expression of ERRγ might provide a
novel treatment for ischemic diseases.
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